SDX 0.00% 7.0¢ sienna cancer diagnostics limited

News: SDX Bard1 Life Sciences And Sienna Cancer Diagnostics Announce Merger

  1. 186,314 Posts.
    lightbulb Created with Sketch. 2735

    April 8 (Reuters) - BARD1 Life Sciences Ltd (BD1) :

    • BARD1 AND SIENNA CANCER DIAGNOSTICS ANNOUNCE MERGER
    • ENTERED INTO A MERGER IMPLEMENTATION AGREEMENT WITH SIENNA CANCER DIAGNOSTICS
    • SIENNA SHAREHOLDERS WILL BE OFFERED 13 NEW SHARES IN BARD1 FOR EVERY 5 SHARES IN SIENNA
    • UNDER DEAL, VALUES EACH SIENNA SHARE AT $0.061
    • DEAL VALUES EACH SIENNA SHARE AT $0.061 PER SHARE & SIENNA AT ABOUT $23.7 MILLION ON FULLY DILUTED BASIS
 
watchlist Created with Sketch. Add SDX (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.